Nature Communications (Jun 2019)

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

  • Christopher S. Lunde,
  • Erin E. Stebbins,
  • Rajiv S. Jumani,
  • Md Mahmudul Hasan,
  • Peter Miller,
  • John Barlow,
  • Yvonne R. Freund,
  • Pamela Berry,
  • Rianna Stefanakis,
  • Jiri Gut,
  • Philip J. Rosenthal,
  • Melissa S. Love,
  • Case W. McNamara,
  • Eric Easom,
  • Jacob J. Plattner,
  • Robert T. Jacobs,
  • Christopher D. Huston

DOI
https://doi.org/10.1038/s41467-019-10687-y
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 11

Abstract

Read online

Cryptosporidium infection can cause severe diarrhea with limited treatment options available. Here, Lunde et al. perform a drug repositioning screen with a library of benzoxaboroles and identify AN7973 as potent inhibitor of intracellular parasite development with good efficacy in murine and neonatal dairy calf disease models.